Structure

Physi-Chem Properties

Molecular Weight:  135.05
Volume:  121.262
LogP:  -2.602
LogD:  -1.937
LogS:  -0.224
# Rotatable Bonds:  3
TPSA:  103.78
# H-Bond Aceptor:  5
# H-Bond Donor:  5
# Rings:  0
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.35
Synthetic Accessibility Score:  3.066
Fsp3:  0.75
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.07
MDCK Permeability:  0.01980169489979744
Pgp-inhibitor:  0.0
Pgp-substrate:  0.037
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.001

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.201
Plasma Protein Binding (PPB):  10.608977317810059%
Volume Distribution (VD):  0.571
Pgp-substrate:  89.72294616699219%

ADMET: Metabolism

CYP1A2-inhibitor:  0.016
CYP1A2-substrate:  0.045
CYP2C19-inhibitor:  0.011
CYP2C19-substrate:  0.061
CYP2C9-inhibitor:  0.012
CYP2C9-substrate:  0.026
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.131
CYP3A4-inhibitor:  0.024
CYP3A4-substrate:  0.052

ADMET: Excretion

Clearance (CL):  1.966
Half-life (T1/2):  0.803

ADMET: Toxicity

hERG Blockers:  0.006
Human Hepatotoxicity (H-HT):  0.369
Drug-inuced Liver Injury (DILI):  0.035
AMES Toxicity:  0.052
Rat Oral Acute Toxicity:  0.009
Maximum Recommended Daily Dose:  0.01
Skin Sensitization:  0.055
Carcinogencity:  0.049
Eye Corrosion:  0.009
Eye Irritation:  0.475
Respiratory Toxicity:  0.088

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC10764

Natural Product ID:  NPC10764
Common Name*:   Phomalevone B
IUPAC Name:   [3-[3-(3,6-dihydroxy-2-methylbenzoyl)-2,4-dihydroxy-6-methylphenyl]-2,6-dihydroxy-4-methylphenyl]-(3,6-dihydroxy-2-methylphenyl)methanone
Synonyms:   Phomalevone B
Standard InCHIKey:  QNGZXAWVLALWLX-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C30H26O10/c1-11-9-19(35)25(29(39)23-13(3)15(31)5-7-17(23)33)27(37)21(11)22-12(2)10-20(36)26(28(22)38)30(40)24-14(4)16(32)6-8-18(24)34/h5-10,31-38H,1-4H3
SMILES:  Cc1cc(O)c(c(c1c1c(C)cc(c(c1O)C(=O)c1c(O)ccc(c1C)O)O)O)C(=O)c1c(O)ccc(c1C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1765415
PubChem CID:   52937280
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0000325] Biphenols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30877 Phoma Genus Didymellaceae Eukaryota n.a. n.a. n.a. PMID[11099218]
NPO30877 Phoma Genus Didymellaceae Eukaryota n.a. n.a. n.a. PMID[11671521]
NPO30877 Phoma Genus Didymellaceae Eukaryota n.a. mycelium n.a. PMID[21247198]
NPO30877 Phoma Genus Didymellaceae Eukaryota n.a. n.a. n.a. Database[Article]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT79 Organism Bacillus subtilis Bacillus subtilis IZ = 38.0 mm PMID[464769]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IZ = 26.0 mm PMID[464769]
NPT20 Organism Candida albicans Candida albicans IZ = 18.0 mm PMID[464769]
NPT19 Organism Escherichia coli Escherichia coli IZ = 18.0 mm PMID[464769]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC10764 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9433 High Similarity NPC227841
0.9371 High Similarity NPC37709
0.9236 High Similarity NPC290194
0.9225 High Similarity NPC293545
0.9225 High Similarity NPC296752
0.9225 High Similarity NPC174905
0.9225 High Similarity NPC313047
0.9225 High Similarity NPC451542
0.9225 High Similarity NPC295712
0.9225 High Similarity NPC474203
0.922 High Similarity NPC246638
0.9209 High Similarity NPC245923
0.9137 High Similarity NPC474813
0.9097 High Similarity NPC471683
0.9085 High Similarity NPC187843
0.9078 High Similarity NPC143438
0.9078 High Similarity NPC242994
0.9078 High Similarity NPC138099
0.9071 High Similarity NPC44960
0.9071 High Similarity NPC474110
0.9051 High Similarity NPC72669
0.9051 High Similarity NPC474517
0.9034 High Similarity NPC271944
0.9034 High Similarity NPC110882
0.9034 High Similarity NPC85393
0.9021 High Similarity NPC19631
0.9021 High Similarity NPC239136
0.9014 High Similarity NPC181560
0.9014 High Similarity NPC169452
0.9 High Similarity NPC191976
0.8986 High Similarity NPC35
0.898 High Similarity NPC477221
0.8966 High Similarity NPC12402
0.8958 High Similarity NPC471682
0.8936 High Similarity NPC53206
0.8936 High Similarity NPC53414
0.8936 High Similarity NPC62272
0.8936 High Similarity NPC471905
0.8933 High Similarity NPC66029
0.8929 High Similarity NPC283088
0.8921 High Similarity NPC267205
0.8889 High Similarity NPC257644
0.8889 High Similarity NPC193555
0.8889 High Similarity NPC474961
0.8865 High Similarity NPC155211
0.8865 High Similarity NPC254847
0.8857 High Similarity NPC282780
0.8857 High Similarity NPC161964
0.8857 High Similarity NPC166480
0.8857 High Similarity NPC287604
0.8857 High Similarity NPC472262
0.8808 High Similarity NPC66508
0.8808 High Similarity NPC226656
0.8777 High Similarity NPC205992
0.8759 High Similarity NPC135524
0.8758 High Similarity NPC324736
0.875 High Similarity NPC225243
0.8732 High Similarity NPC118919
0.8732 High Similarity NPC272268
0.8723 High Similarity NPC44437
0.8701 High Similarity NPC470342
0.8701 High Similarity NPC476506
0.8701 High Similarity NPC472060
0.8701 High Similarity NPC472052
0.8696 High Similarity NPC48248
0.869 High Similarity NPC204045
0.869 High Similarity NPC305845
0.8681 High Similarity NPC190457
0.8671 High Similarity NPC53001
0.8667 High Similarity NPC205766
0.8662 High Similarity NPC161632
0.8652 High Similarity NPC225051
0.8652 High Similarity NPC314048
0.8639 High Similarity NPC471906
0.8639 High Similarity NPC193703
0.8639 High Similarity NPC21599
0.8639 High Similarity NPC244691
0.8636 High Similarity NPC177650
0.8633 High Similarity NPC99731
0.8633 High Similarity NPC92624
0.8618 High Similarity NPC470408
0.8618 High Similarity NPC182921
0.8618 High Similarity NPC218870
0.8618 High Similarity NPC474824
0.8611 High Similarity NPC13715
0.8611 High Similarity NPC87723
0.8592 High Similarity NPC12070
0.8582 High Similarity NPC175738
0.8581 High Similarity NPC312993
0.8581 High Similarity NPC186325
0.8581 High Similarity NPC34482
0.8581 High Similarity NPC68441
0.8571 High Similarity NPC259942
0.8571 High Similarity NPC238629
0.8562 High Similarity NPC106519
0.8562 High Similarity NPC91019
0.8562 High Similarity NPC110810
0.8562 High Similarity NPC290550
0.8561 High Similarity NPC282923
0.8543 High Similarity NPC315520
0.8543 High Similarity NPC294646
0.8542 High Similarity NPC305060
0.854 High Similarity NPC173978
0.8535 High Similarity NPC476505
0.8531 High Similarity NPC249272
0.8526 High Similarity NPC273467
0.8526 High Similarity NPC189552
0.8523 High Similarity NPC470570
0.8521 High Similarity NPC114183
0.8521 High Similarity NPC115458
0.8514 High Similarity NPC48762
0.8511 High Similarity NPC244699
0.8511 High Similarity NPC85342
0.8506 High Similarity NPC474861
0.8503 High Similarity NPC85310
0.8503 High Similarity NPC73061
0.8503 High Similarity NPC137649
0.8497 Intermediate Similarity NPC135522
0.8483 Intermediate Similarity NPC20210
0.8481 Intermediate Similarity NPC71390
0.8477 Intermediate Similarity NPC329933
0.8467 Intermediate Similarity NPC34802
0.8462 Intermediate Similarity NPC270899
0.8462 Intermediate Similarity NPC50924
0.8451 Intermediate Similarity NPC58685
0.8447 Intermediate Similarity NPC477836
0.8442 Intermediate Similarity NPC254351
0.844 Intermediate Similarity NPC55949
0.844 Intermediate Similarity NPC31539
0.8435 Intermediate Similarity NPC477275
0.8428 Intermediate Similarity NPC30027
0.8421 Intermediate Similarity NPC227122
0.8417 Intermediate Similarity NPC160499
0.8417 Intermediate Similarity NPC96915
0.8417 Intermediate Similarity NPC267846
0.8403 Intermediate Similarity NPC80035
0.8403 Intermediate Similarity NPC290803
0.84 Intermediate Similarity NPC143685
0.84 Intermediate Similarity NPC147250
0.84 Intermediate Similarity NPC314437
0.84 Intermediate Similarity NPC476535
0.8397 Intermediate Similarity NPC186113
0.8397 Intermediate Similarity NPC18699
0.8397 Intermediate Similarity NPC55443
0.8392 Intermediate Similarity NPC180261
0.8392 Intermediate Similarity NPC37299
0.8392 Intermediate Similarity NPC53896
0.8378 Intermediate Similarity NPC469520
0.8377 Intermediate Similarity NPC329844
0.8377 Intermediate Similarity NPC472211
0.8377 Intermediate Similarity NPC95842
0.8377 Intermediate Similarity NPC280530
0.8377 Intermediate Similarity NPC178964
0.8369 Intermediate Similarity NPC34414
0.8369 Intermediate Similarity NPC146647
0.8369 Intermediate Similarity NPC474998
0.8369 Intermediate Similarity NPC109123
0.8367 Intermediate Similarity NPC203063
0.8367 Intermediate Similarity NPC96421
0.8365 Intermediate Similarity NPC469664
0.8357 Intermediate Similarity NPC72158
0.8357 Intermediate Similarity NPC23126
0.8357 Intermediate Similarity NPC98254
0.8357 Intermediate Similarity NPC116513
0.8357 Intermediate Similarity NPC103356
0.8357 Intermediate Similarity NPC266689
0.8357 Intermediate Similarity NPC30501
0.8357 Intermediate Similarity NPC162612
0.8357 Intermediate Similarity NPC471530
0.8357 Intermediate Similarity NPC105157
0.8357 Intermediate Similarity NPC190043
0.8357 Intermediate Similarity NPC169250
0.8357 Intermediate Similarity NPC100067
0.8356 Intermediate Similarity NPC473622
0.8356 Intermediate Similarity NPC123714
0.8356 Intermediate Similarity NPC4214
0.8354 Intermediate Similarity NPC15374
0.8345 Intermediate Similarity NPC477454
0.8345 Intermediate Similarity NPC103540
0.8344 Intermediate Similarity NPC245584
0.8344 Intermediate Similarity NPC289042
0.8344 Intermediate Similarity NPC312929
0.8344 Intermediate Similarity NPC162751
0.8344 Intermediate Similarity NPC52161
0.8344 Intermediate Similarity NPC56433
0.8344 Intermediate Similarity NPC126767
0.8344 Intermediate Similarity NPC284495
0.8344 Intermediate Similarity NPC118027
0.8344 Intermediate Similarity NPC190648
0.8333 Intermediate Similarity NPC44199
0.8323 Intermediate Similarity NPC318270
0.8322 Intermediate Similarity NPC84266
0.8322 Intermediate Similarity NPC70622
0.8321 Intermediate Similarity NPC196976
0.8313 Intermediate Similarity NPC477835
0.8312 Intermediate Similarity NPC175978
0.8311 Intermediate Similarity NPC92079
0.8311 Intermediate Similarity NPC124365
0.8301 Intermediate Similarity NPC147735
0.8301 Intermediate Similarity NPC255641

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC10764 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9433 High Similarity NPD7390 Discontinued
0.8936 High Similarity NPD5405 Approved
0.8936 High Similarity NPD5406 Approved
0.8936 High Similarity NPD5404 Approved
0.8936 High Similarity NPD5408 Approved
0.8865 High Similarity NPD1509 Clinical (unspecified phase)
0.8581 High Similarity NPD7422 Clinical (unspecified phase)
0.8408 Intermediate Similarity NPD6959 Discontinued
0.8345 Intermediate Similarity NPD1470 Approved
0.8321 Intermediate Similarity NPD1201 Approved
0.8239 Intermediate Similarity NPD6232 Discontinued
0.8199 Intermediate Similarity NPD7473 Discontinued
0.7945 Intermediate Similarity NPD943 Approved
0.7857 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD7768 Phase 2
0.78 Intermediate Similarity NPD2935 Discontinued
0.775 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD7819 Suspended
0.7665 Intermediate Similarity NPD5844 Phase 1
0.7658 Intermediate Similarity NPD3226 Approved
0.7654 Intermediate Similarity NPD3749 Approved
0.763 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD2533 Approved
0.7628 Intermediate Similarity NPD2532 Approved
0.7628 Intermediate Similarity NPD2534 Approved
0.761 Intermediate Similarity NPD4380 Phase 2
0.76 Intermediate Similarity NPD1607 Approved
0.7586 Intermediate Similarity NPD1164 Approved
0.7578 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD2801 Approved
0.7562 Intermediate Similarity NPD7411 Suspended
0.7516 Intermediate Similarity NPD2346 Discontinued
0.75 Intermediate Similarity NPD1510 Phase 2
0.75 Intermediate Similarity NPD3300 Phase 2
0.75 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD3750 Approved
0.7484 Intermediate Similarity NPD7003 Approved
0.7467 Intermediate Similarity NPD1240 Approved
0.7443 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD6559 Discontinued
0.7413 Intermediate Similarity NPD3019 Approved
0.7386 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD6166 Phase 2
0.7381 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD5494 Approved
0.7342 Intermediate Similarity NPD1511 Approved
0.7341 Intermediate Similarity NPD8312 Approved
0.7341 Intermediate Similarity NPD8313 Approved
0.7338 Intermediate Similarity NPD7635 Approved
0.7333 Intermediate Similarity NPD3764 Approved
0.7301 Intermediate Similarity NPD1934 Approved
0.7292 Intermediate Similarity NPD2932 Approved
0.729 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD6535 Approved
0.7263 Intermediate Similarity NPD6534 Approved
0.725 Intermediate Similarity NPD1512 Approved
0.7244 Intermediate Similarity NPD1549 Phase 2
0.7229 Intermediate Similarity NPD7075 Discontinued
0.7226 Intermediate Similarity NPD2342 Discontinued
0.7222 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD8150 Discontinued
0.7212 Intermediate Similarity NPD5402 Approved
0.7197 Intermediate Similarity NPD2800 Approved
0.7169 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD3748 Approved
0.7161 Intermediate Similarity NPD2799 Discontinued
0.7158 Intermediate Similarity NPD6778 Approved
0.7158 Intermediate Similarity NPD6781 Approved
0.7158 Intermediate Similarity NPD6782 Approved
0.7158 Intermediate Similarity NPD6780 Approved
0.7158 Intermediate Similarity NPD6779 Approved
0.7158 Intermediate Similarity NPD6777 Approved
0.7158 Intermediate Similarity NPD6776 Approved
0.7152 Intermediate Similarity NPD4625 Phase 3
0.7143 Intermediate Similarity NPD7700 Phase 2
0.7143 Intermediate Similarity NPD7699 Phase 2
0.7126 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7122 Intermediate Similarity NPD4750 Phase 3
0.7115 Intermediate Similarity NPD2796 Approved
0.7097 Intermediate Similarity NPD7870 Phase 2
0.7097 Intermediate Similarity NPD7871 Phase 2
0.7081 Intermediate Similarity NPD6823 Phase 2
0.707 Intermediate Similarity NPD2344 Approved
0.7066 Intermediate Similarity NPD3882 Suspended
0.7059 Intermediate Similarity NPD5710 Approved
0.7059 Intermediate Similarity NPD5711 Approved
0.7052 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7052 Intermediate Similarity NPD6020 Phase 2
0.7048 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD1465 Phase 2
0.7043 Intermediate Similarity NPD7696 Phase 3
0.7043 Intermediate Similarity NPD7698 Approved
0.7043 Intermediate Similarity NPD7435 Discontinued
0.7043 Intermediate Similarity NPD7697 Approved
0.7037 Intermediate Similarity NPD8151 Discontinued
0.7032 Intermediate Similarity NPD6651 Approved
0.7017 Intermediate Similarity NPD6213 Phase 3
0.7017 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7017 Intermediate Similarity NPD6212 Phase 3
0.7011 Intermediate Similarity NPD7074 Phase 3
0.7007 Intermediate Similarity NPD3026 Approved
0.7007 Intermediate Similarity NPD3023 Approved
0.7006 Intermediate Similarity NPD1551 Phase 2
0.7006 Intermediate Similarity NPD3817 Phase 2
0.7006 Intermediate Similarity NPD6100 Approved
0.7006 Intermediate Similarity NPD6099 Approved
0.6994 Remote Similarity NPD3818 Discontinued
0.6993 Remote Similarity NPD2313 Discontinued
0.6993 Remote Similarity NPD5951 Approved
0.6993 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6989 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6988 Remote Similarity NPD37 Approved
0.6988 Remote Similarity NPD6801 Discontinued
0.6986 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6986 Remote Similarity NPD3025 Approved
0.6986 Remote Similarity NPD1651 Approved
0.6986 Remote Similarity NPD3024 Approved
0.6981 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6971 Remote Similarity NPD7993 Clinical (unspecified phase)
0.697 Remote Similarity NPD6599 Discontinued
0.6954 Remote Similarity NPD7054 Approved
0.6954 Remote Similarity NPD2798 Approved
0.6939 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6937 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6937 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6933 Remote Similarity NPD1283 Approved
0.6914 Remote Similarity NPD7472 Approved
0.6913 Remote Similarity NPD9269 Phase 2
0.6909 Remote Similarity NPD7458 Discontinued
0.6905 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6897 Remote Similarity NPD7177 Discontinued
0.6895 Remote Similarity NPD7701 Phase 2
0.6894 Remote Similarity NPD2309 Approved
0.6882 Remote Similarity NPD6234 Discontinued
0.6878 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7783 Phase 2
0.6875 Remote Similarity NPD497 Approved
0.6875 Remote Similarity NPD6797 Phase 2
0.6871 Remote Similarity NPD9268 Approved
0.6864 Remote Similarity NPD4965 Approved
0.6864 Remote Similarity NPD4966 Approved
0.6864 Remote Similarity NPD4967 Phase 2
0.6863 Remote Similarity NPD4908 Phase 1
0.6861 Remote Similarity NPD940 Approved
0.6861 Remote Similarity NPD846 Approved
0.686 Remote Similarity NPD7229 Phase 3
0.6839 Remote Similarity NPD5033 Approved
0.6836 Remote Similarity NPD5031 Approved
0.6836 Remote Similarity NPD5027 Approved
0.6836 Remote Similarity NPD5029 Approved
0.6836 Remote Similarity NPD7251 Discontinued
0.6832 Remote Similarity NPD8166 Discontinued
0.6832 Remote Similarity NPD3400 Discontinued
0.6825 Remote Similarity NPD8320 Phase 1
0.6825 Remote Similarity NPD8319 Approved
0.6824 Remote Similarity NPD2286 Discontinued
0.6823 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6823 Remote Similarity NPD7874 Approved
0.6821 Remote Similarity NPD3926 Phase 2
0.6818 Remote Similarity NPD7008 Discontinued
0.681 Remote Similarity NPD6799 Approved
0.6809 Remote Similarity NPD74 Approved
0.6809 Remote Similarity NPD9266 Approved
0.6806 Remote Similarity NPD496 Approved
0.6806 Remote Similarity NPD495 Approved
0.6806 Remote Similarity NPD498 Approved
0.6802 Remote Similarity NPD1247 Approved
0.6798 Remote Similarity NPD4954 Approved
0.6798 Remote Similarity NPD5028 Approved
0.6798 Remote Similarity NPD4955 Approved
0.6798 Remote Similarity NPD7808 Phase 3
0.6798 Remote Similarity NPD5034 Approved
0.6798 Remote Similarity NPD36 Approved
0.6798 Remote Similarity NPD5026 Approved
0.6788 Remote Similarity NPD5403 Approved
0.6788 Remote Similarity NPD920 Approved
0.6788 Remote Similarity NPD7801 Approved
0.6788 Remote Similarity NPD1242 Phase 1
0.6788 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6782 Remote Similarity NPD7654 Discontinued
0.6781 Remote Similarity NPD9493 Approved
0.678 Remote Similarity NPD5953 Discontinued
0.677 Remote Similarity NPD1243 Approved
0.6768 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6763 Remote Similarity NPD3787 Discontinued
0.6758 Remote Similarity NPD4287 Approved
0.6752 Remote Similarity NPD230 Phase 1
0.6742 Remote Similarity NPD5030 Phase 2
0.6742 Remote Similarity NPD5039 Approved
0.674 Remote Similarity NPD5038 Approved
0.674 Remote Similarity NPD5037 Approved
0.6738 Remote Similarity NPD9263 Approved
0.6738 Remote Similarity NPD9264 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data